BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

183 related articles for article (PubMed ID: 8424270)

  • 1. Granulocyte-macrophage-colony-stimulating factor: a review from preclinical development to clinical application.
    Neumanaitis J
    Transfusion; 1993 Jan; 33(1):70-83. PubMed ID: 8424270
    [No Abstract]   [Full Text] [Related]  

  • 2. Mean myeloperoxidase index in lymphoma transplants receiving recombinant granulocyte-macrophage colony stimulating factor.
    Tsakona CP; Khwaja A; Goldstone AH
    Bone Marrow Transplant; 1993 Apr; 11(4):345-6. PubMed ID: 8387371
    [No Abstract]   [Full Text] [Related]  

  • 3. [Cytokines and diseases. Clinical applications of RhG-CSF].
    Asano S
    Nihon Naika Gakkai Zasshi; 1991 Sep; 80(9):1388-96. PubMed ID: 1761917
    [No Abstract]   [Full Text] [Related]  

  • 4. Emerging applications of recombinant human granulocyte-macrophage colony-stimulating factor.
    Armitage JO
    Blood; 1998 Dec; 92(12):4491-508. PubMed ID: 9845514
    [No Abstract]   [Full Text] [Related]  

  • 5. Cost considerations in therapy with myeloid growth factors.
    Glaspy JA; Jakway J
    Am J Hosp Pharm; 1993 Jul; 50(7 Suppl 3):S19-26. PubMed ID: 7689789
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Hematopoietic colony-stimulating factors.
    Andreeff M; Welte K
    Semin Oncol; 1989 Jun; 16(3):211-29. PubMed ID: 2471272
    [No Abstract]   [Full Text] [Related]  

  • 7. Recombinant granulocyte-macrophage colony-stimulating factor after autologous bone marrow transplantation for lymphoid cancer.
    Nemunaitis J; Rabinowe SN; Singer JW; Bierman PJ; Vose JM; Freedman AS; Onetto N; Gillis S; Oette D; Gold M
    N Engl J Med; 1991 Jun; 324(25):1773-8. PubMed ID: 1903847
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Use of granulocyte-macrophage colony-stimulating factor in hematopoietic disorders: biology and nature of response.
    Vadhan-Raj S; Broxmeyer HE; Hittelman WN
    Semin Hematol; 1992 Oct; 29(4 Suppl 3):4-13. PubMed ID: 1492234
    [No Abstract]   [Full Text] [Related]  

  • 9. Clinical experience with Escherichia coli rHuGM-CSF.
    Stern AC; Jones TC
    Int Rev Exp Pathol; 1993; 34 Pt B():209-16. PubMed ID: 8458714
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Plasma lactoferrin content in neutropenic patients: effects of treatment with recombinant granulocyte-macrophage colony-stimulating factor.
    Bezwoda WR; Dajee D
    Mol Biother; 1992 Jun; 4(2):103-6. PubMed ID: 1515094
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Granulocyte colony-stimulating factors.
    Med Lett Drugs Ther; 1991 Jun; 33(847):61-3. PubMed ID: 1710761
    [No Abstract]   [Full Text] [Related]  

  • 12. Haemopoietic growth factors and childhood cancer.
    Hann IM
    Eur J Cancer; 1995; 31A(9):1476-8. PubMed ID: 7577075
    [No Abstract]   [Full Text] [Related]  

  • 13. Clinical effects of biologic response modifiers.
    Louie SG; Jung B
    Am J Hosp Pharm; 1993 Jul; 50(7 Suppl 3):S10-8. PubMed ID: 7689788
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Granulocyte colony-stimulating factor and granulocyte-macrophage colony-stimulating factor (2).
    Lieschke GJ; Burgess AW
    N Engl J Med; 1992 Jul; 327(2):99-106. PubMed ID: 1376442
    [No Abstract]   [Full Text] [Related]  

  • 15. Indications and guidelines for the use of hematopoietic growth factors.
    Goodnough LT; Anderson KC; Kurtz S; Lane TA; Pisciotto PT; Sayers MH; Silberstein LE
    Transfusion; 1993; 33(11):944-59. PubMed ID: 7505068
    [No Abstract]   [Full Text] [Related]  

  • 16. Colony-stimulating factors for the management of neutropenia in cancer patients.
    Dale DC
    Drugs; 2002; 62 Suppl 1():1-15. PubMed ID: 12479591
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Myeloid growth factors can cure chronic neutropenia and facilitate cytostatic therapy].
    Palmblad J; Samuelsson J
    Lakartidningen; 1992 Mar; 89(13):1037-8, 1041. PubMed ID: 1372671
    [No Abstract]   [Full Text] [Related]  

  • 18. Hematopoietic growth factors in pediatrics.
    Frenck RW; Shannon KM
    Curr Opin Pediatr; 1993 Feb; 5(1):94-102. PubMed ID: 7690636
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Hematopoietic growth factors].
    Fillet G
    Rev Med Liege; 1996 Jan; 51(1):102-6. PubMed ID: 8701118
    [No Abstract]   [Full Text] [Related]  

  • 20. [Hematopoietic growth factors in the treatment of acute myeloblastic leukemia].
    de la Rubia Comos J
    Sangre (Barc); 1997 Apr; 42 Suppl 1():32-3. PubMed ID: 9381298
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 10.